Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches

Abstract The exact cause of psoriasis is still unclear and there is no treatment available for its permanent reemission. The available biologics for disease treatment, are stated to be associated with a high cost of treatment, a significantly increased risk of serious infections, and have also been...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Saumya Choudhary, Noor Saba Khan, Pallavi Saxena, Parameswar Sahu, Dibyabhaba Pradhan, Harpreet Singh, George Thomas, Neeraj Kumar
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2025-07-01
coleção:	Scientific Reports
Assuntos:	Psoriasis Drug repurposing FDA approved drugs Drug-target Molecular docking and simulation One-SVM algorithm
Acesso em linha:	https://doi.org/10.1038/s41598-025-01448-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!